ARA-290 is variant of erythropoietin which has been shown to decrease inflammatory pathways through paracrine signalling and the innate repair receptors. Research has shown ARA-290 to help reduce HbA1c, improve cholesterol, modulate neuropathic pain and stimulate wound repair.
ARA-290 16mg
$95.00
ARA-290 is variant of erythropoietin which has been shown to decrease inflammatory pathways through paracrine signalling and the innate repair receptors. Research has shown ARA-290 to help reduce HbA1c, improve cholesterol, modulate neuropathic pain and stimulate wound repair.
Related products
Acetyl Hexapeptide-3 (Argireline) 200mg (Topical)
Adipotide (FTPP) 10mg
Gut Inflammation (60 Capsules) (Stable BPC-157 Arginate, KPV, Larazotide) FREE Shipping
Ipamorelin
MK-677 (Ibutamoren) 12.5mg (60 Capsules)
MK-677, is a orally bio-active, selective agonist of the ghrelin receptor. Research shows that MK-677 increases the natural secretion of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), but does not affect cortisol levels. It is being researched as a possible treatment for GH deficiency, muscle and bone wasting, appetite stimulation and Alzheimer's disease. MK-677 research in mice, appeared to prevent the onset of AD, even in genetically predisposed mice, as long as it was started before significant amyloid beta accumulation. MK-677 research has also shown exceptionally promising benefits in improving sleep quality.
Semaglutide
Semaglutide is a widely researched peptide-based compound recognized for its significant role in metabolic regulation and appetite control. It belongs to the class of GLP-1 receptor agonists, which are designed to mimic naturally occurring hormones involved in glucose metabolism and satiety signaling.
Semaglutide 3m
Semaglutide is a widely researched peptide-based compound recognized for its significant role in metabolic regulation and appetite control. It belongs to the class of GLP-1 receptor agonists, which are designed to mimic naturally occurring hormones involved in glucose metabolism and satiety signaling.
SLU-PP-332
SLU-PP-332 (250mcg x 60 Capsules = 15,000mcg) SLU-PP-332 (1000mcg x 30 Capsules = 30,000mcg) SLU-PP-332 is an experimental compound designed to mimic the metabolic effects of exercise by activating estrogen-related receptors (ERRs), particularly ERRα, ERRβ, and ERRγ. This activation leads to increased energy expenditure, enhanced fatty acid oxidation, and improved mitochondrial function.

Reviews
There are no reviews yet.